FilingReader Intelligence
Maccura Biotechnology shareholder cuts stake to 6.62%
August 23, 2025 at 06:23 AM UTC•By FilingReader AI
Shareholder Guo Lei and affiliated Shanghai Axing Investment Management sold 6.06 million Maccura Biotechnology shares between August 4-21, reducing their combined stake from 7.62% to 6.62%.
The sale was driven by Guo Lei's personal funding needs and does not affect company control.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Maccura Biotechnology publishes news
Free account required • Unsubscribe anytime